silybin has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellanti, F; Giudetti, AM; Serviddio, G; Siculella, L; Stanca, E; Vendemiale, G | 1 |
1 other study(ies) available for silybin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: potential antiinflammatory effect of silybin.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Antioxidants; Blotting, Western; Chromatography, Thin Layer; Down-Regulation; Gene Expression Regulation; Inflammation; Liver Cirrhosis; Male; Microsomes, Liver; Phospholipases A2; Platelet Activating Factor; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Silybin; Silymarin | 2013 |